Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Financial plays

Financial plays

Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.

DSM profits rise 27% but nutrition space ‘sluggish’ as omega-3 bites

DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient...

Sweet sales future for fructose products?

EFSA backing of a blood glucose lowering health claim for fructose products spells good business prospects, Israeli supplier of the ingredient Galam Group has said.

NourishLife revokes Speak claims to follow National Advertising Division recommendations

A dietary supplement claiming to provoke remarkable speech gains in children has removed these claims from its website and is in the process of removing it from product packaging after...

Fytexia targets US expansion with new US-structure and Med Diet science

French raw material supplier Fytexia wants to more than double its US business within five years by bringing the benefits of the Mediterranean Diet to North America, as it opens...

Beyond caffeine: Alternative energy boosters

As consumer perceptions of caffeine shift and the threat of more market regulation looms, companies are scrambling to find the next blockbuster to cater to demand for energy-boosting products, says...

New firm seals deal on £35m omega-3 acquisitions

New London based supplement firm Burr and Burr has announced the completion of two brand acquisitions totalling £35m within the omega-3 health supplement sector.

UK sports nutrition: One year on from 20% beefcake tax hike

One year on from the 20% VAT hike for some sports nutrition products in the UK, NutraIngredients looks at what the move has meant for the UK industry.

News in brief

Tate & Lyle ‘compelling’ despite price: City

Tate & Lyle’s prospects remain encouraging despite the poor share price, news revealed today (October 4) in its trading update for the six months to September 30, says City analyst Investec.

Swedes invest €4.3m in Norwegian medical omega-3 player

Norwegian high-dose omega-3 player Smartfish is investing in new studies, an R&D facility and regional growth after winning a €4.3m (SEK35m) investment from a Swedish government-backed venture capital firm....

SOLD! GSK exits drinks market

Glaxo sells Lucozade and Ribena to Suntory for £1.35bn cash

Ever-expanding Japanese beverage behemoth, Suntory, is the new owner of Lucozade and Ribena, which GlaxoSmithKline (GSK) has sold for £1.35bn (€1.6bn/$2.11bn) as it admits defeat in its internationalisation plans and...

Big changes at Chr Hansen

Nature lover: Chr Hansen plays natural card in 6-platform reinvention

Danish ingredients giant Chr Hansen has today rebranded itself ‘Nature’s Number 1’ as it announced a 6-platform strategic overhaul of its colours, enzymes and cultures businesses.

Arla profits boom as mergers bear fruit

Dairy giant Arla has doubled profits for the first half of its financial year, amid news the two mergers it undertook in 2012 were paying off.

Emerging market focus delivers Benecol cholesterol reduction bounty

Finnish ag-ingredients-branded foods player Raisio has turned in its best ever quarter and said a focus on emerging markets is driving ongoing sales growth in the sluggish plant stanol, cholesterol...

Nestlé creates ‘turnaround plan’ for underperforming Jenny Craig

As Nestlé put a brave face on underwhelming first half results that fell far below market expectations, its Jenny Craig weight management brand was singled out as being one of...

Sluggish UK brands don’t blight Kerry Foods’ figures

Food firm Kerry Group has posted promising half yearly figures despite UK brands flat-lining in spreads and frozen food as a result of heavy promotions and the horsemeat effect.

Nestlé cuts growth forecast as Q2 sales miss expectations

Nestlé has cut its sales growth expectations for the full year – but even the revised target will be a stretch, according to the company’s financial chief.

Nutrition division drives DSM Q2 profits up 19%

Organic growth and a healthy boost from last year’s €500m Fortitech investment lifted Q2 pre-tax profits 19% to €345m at Dutch ingredients and chemicals giant, Royal DSM.

Nichols eyes Ribena, Lucozade sale

Soft drinks firm Nichols may be considering a bid for GlaxoSmithKline (GSK) beverage brands Ribena and Lucozade.

Solvay management buys out Solactis

€13bn Belgian supplier Solvay has sold its Solactis nutrition division that includes galactofructose  (lactulose) to its former nutrition programme manager.

Tate & Lyle meeting profit targets despite 4% US soft drink slide

Tate & Lyle CEO Javed Ahmed says earning and profit forecasts are intact – “mid single digit growth” – despite an unseasonably cold spring that has contributed to an annual drop of...

Irish microbiota research centre to receive €50m boost

The Alimentary Pharmabiotic Centre (APC) in Cork, Ireland has received a €36m investment from the Irish government that will fund its research activities for at least another six years, its...

Provexis seeks to demerge Science in Sport and Fruitflow

UK firm Provexis has filed to demerge the Science in Sport (SiS) consumer sports brand it purchased for €10m in June 2011 from its Fruitflow tomato-based ingredients business, as it...

Bioseutica sells high-end omega-3 division to German equity firm; major expansion planned

Swiss nutra and pharma ingredient player Bioseutica has sold 85% of its KD Pharma high-end omega-3 business to German equity firm Capiton. Serious expansion is planned.

Exclusive interview

Naturex CEO talks HQ expansion, green credentials and the memory of Jacques Dikansky

Naturex hosted 500 of its employees and guests the weekend just passed as it inaugurated a €12m expansion of its Avignon HQ in southern France. We caught up with CEO...

DSM Q1 sales steady; happy with acquisitions

Strong nutrition sales drove a steady quarter at DSM with sales up 10% in that division, as EBITDA profits improved €5m across the company to €311m compared to €306m in Q1 2012.

Key Industry Events